PURPOSE: Breast cancer radiotherapy has been associated with an increased risk of cardiac toxicity. However, no data are available on the probability of developing coronary artery disease (CAD) in breast cancer patients when compared with healthy women. Therefore, baseline coronary artery calcium (CAC) scores, as an accepted tool to predict CAD, were determined and compared with the CAC scores of a healthy, asymptomatic cohort, the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. METHODS AND MATERIALS: Eighty consecutive patients with ductal carcinoma in situ or infiltrative breast cancer referred for radiotherapy after breast-conserving surgery were included in our study. Their cardiovascular risk profile was registered, and a 64 multislice CT scan was performed. The CAC scores of an unselected (Caucasian only) Radiotherapy Centre West (RCWEST) cohort, as well as of those of a selected (comorbidity and race adjusted) RCWEST cohort, were determined. The scores of both cohorts were compared with those of the female (Caucasian only) MESA cohort. RESULTS: For the unselected RCWEST cohort (n = 62) we found significant (p < .01) higher scores for women in the 55-64 age category compared with those of the MESA cohort. In the selected cohort (n = 55) the CAC scores of the women in the age category 55-64 were significantly (p = .02) higher compared with the MESA cohort. No significant differences were noted in the other age categories. CONCLUSION: Both cohorts revealed that CAC scores in the 55-64 age category were significantly higher than the CAC scores in the asymptomatic (female) MESA population. These data suggest that breast cancer patients bear a higher risk of developing coronary heart disease before the start of radiotherapy. Therefore, measures to decrease cardiac dose further in breast cancer radiotherapy are even more important.
PURPOSE:Breast cancer radiotherapy has been associated with an increased risk of cardiac toxicity. However, no data are available on the probability of developing coronary artery disease (CAD) in breast cancerpatients when compared with healthy women. Therefore, baseline coronary artery calcium (CAC) scores, as an accepted tool to predict CAD, were determined and compared with the CAC scores of a healthy, asymptomatic cohort, the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. METHODS AND MATERIALS: Eighty consecutive patients with ductal carcinoma in situ or infiltrative breast cancer referred for radiotherapy after breast-conserving surgery were included in our study. Their cardiovascular risk profile was registered, and a 64 multislice CT scan was performed. The CAC scores of an unselected (Caucasian only) Radiotherapy Centre West (RCWEST) cohort, as well as of those of a selected (comorbidity and race adjusted) RCWEST cohort, were determined. The scores of both cohorts were compared with those of the female (Caucasian only) MESA cohort. RESULTS: For the unselected RCWEST cohort (n = 62) we found significant (p < .01) higher scores for women in the 55-64 age category compared with those of the MESA cohort. In the selected cohort (n = 55) the CAC scores of the women in the age category 55-64 were significantly (p = .02) higher compared with the MESA cohort. No significant differences were noted in the other age categories. CONCLUSION: Both cohorts revealed that CAC scores in the 55-64 age category were significantly higher than the CAC scores in the asymptomatic (female) MESA population. These data suggest that breast cancerpatients bear a higher risk of developing coronary heart disease before the start of radiotherapy. Therefore, measures to decrease cardiac dose further in breast cancer radiotherapy are even more important.
Authors: Marta Nowakowska; Edyta Płońska-Gościniak; Andrzej Szyszka; Łukasz Chrzanowski; Magdalena Krakowska; Piotr Potemski; Katarzyna Mizia-Stec; Zbigniew Gąsior; Artur Bodys; Maciej Siński; Adrianna Gościńska-Szmagała; Piotr Gościniak; Monika Różewicz; Beata Zaborska; Wojciech Braksator; Dariusz Kosior; Jarosław D Kasprzak Journal: Arch Med Sci Date: 2020-11-02 Impact factor: 3.318
Authors: Anel Yakupovich; Mark A Davison; Michael Z Kharouta; Julius Turian; Christopher W Seder; Marta Batus; Louis F Fogg; Dinesh Kalra; Mark Kosinski; Tuncay Taskesen; Tochukwu M Okwuosa Journal: J Thorac Dis Date: 2020-03 Impact factor: 2.895
Authors: Juan C Lopez-Mattei; Eric H Yang; Maros Ferencik; Lauren A Baldassarre; Susan Dent; Matthew J Budoff Journal: JACC CardioOncol Date: 2021-12-21
Authors: Arnethea L Sutton; Ashley S Felix; Dipankar Bandyopadhyay; Reuben Retnam; William G Hundley; Vanessa B Sheppard Journal: Breast Cancer Res Treat Date: 2021-04-02 Impact factor: 4.624
Authors: Matthew C Whitlock; Joseph Yeboah; Gregory L Burke; Haiying Chen; Heidi D Klepin; W Gregory Hundley Journal: J Am Heart Assoc Date: 2015-11-09 Impact factor: 5.501
Authors: William J Phillips; Christopher Johnson; Angeline Law; Michele Turek; Alex R Small; Joao R Inacio; Susan Dent; Terrence Ruddy; Rob S Beanlands; Benjamin J W Chow; Gary R Small Journal: Int J Cardiol Heart Vasc Date: 2018-02-11